Urinary enzymes and calcium oxalate urolithiasis

Area of Science:

• Nephrology
• Urology
• Biochemistry

Background:

• Hyperoxaluria is a condition characterized by elevated oxalate levels in the urine.
• Oxalate in urine can lead to kidney stone formation and renal damage.
• Understanding the biochemical markers associated with hyperoxaluria is crucial for diagnosis and management.

Purpose of the Study:

• To investigate the impact of various hyperoxaluric agents on urinary oxalate and renal enzyme levels in a rat model.
• To identify potential urinary biomarkers for hyperoxaluria.

Main Methods:

• Male Sprague-Dawley rats were administered hyperoxaluric agents: ammonium oxalate, hydroxy-L-proline, and ethylene glycol.
• Urinary oxalate levels were measured.
• Urinary levels of renal enzymes including gamma-glutamyl transpeptidase, N-acetyl-beta-glucosaminidase, alkaline phosphatase, and beta-galactosidase were quantified.

Main Results:

• All tested agents successfully induced hyperoxaluria, marked by increased urinary oxalate.
• Hyperoxaluric rats exhibited elevated urinary levels of gamma-glutamyl transpeptidase, N-acetyl-beta-glucosaminidase, and alkaline phosphatase.
• A significant positive correlation was observed between urinary oxalate and N-acetyl-beta-glucosaminidase levels.
• Urinary beta-galactosidase levels remained largely unchanged across treatments.

Conclusions:

• Hyperoxaluric agents reliably increase urinary oxalate and specific renal enzymes in rats.
• Urinary N-acetyl-beta-glucosaminidase emerges as a promising biomarker for hyperoxaluria due to its strong correlation with oxalate levels.
• These findings contribute to understanding the renal response to hyperoxaluria and identifying potential diagnostic markers.